---
schema_version: "secwatch.filing_event.v1"
accession: "0001575872-24-000114"
form_type: "8-K"
ticker: "SXTP"
cik: "0001946563"
company_name: "60 DEGREES PHARMACEUTICALS, INC."
filed_at: "2024-02-02T23:59:59+00:00"
generated_at: "2026-06-06T10:14:40.000609+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# 60 Degrees Pharmaceuticals closes $2.4M public offering of units and pre-funded units

## Summary
- Gross proceeds ~$2.4M; net proceeds ~$1.9M after underwriter discounts and expenses.
- Offering included 5,260,901 units at $0.385/unit and 999,076 pre-funded units at $0.375/unit.
- Each unit consists of one share of common stock and one warrant (exercise price $0.4235, 5-year term).
- Underwriters partially exercised over-allotment for 818,177 warrants.
- Net proceeds to fund working capital, relaunch of ARAKODA malaria prevention, and R&D.

## SEC filing metadata
- accession: 0001575872-24-000114
- form_type: 8-K
- ticker: SXTP
- cik: 0001946563
- company_name: 60 DEGREES PHARMACEUTICALS, INC.
- filed_at: 2024-02-02T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 8.01, 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1946563/000157587224000114/0001575872-24-000114-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1946563/000157587224000114/sxtp-20240129.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001575872-24-000114
- JSON: https://secwatch.observer/filing/0001575872-24-000114.json
- Plain text: https://secwatch.observer/filing/0001575872-24-000114.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.